CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies

Clinical trial NCT04214886 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04214886
Sponsor: Loyola University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Acute Lymphoblastic Leukemia, Adult B-cell Lymphoma Refractory B-cell Lymphoma Recurrent

Start date: 2019-12-31
Primary completion: 2022-08-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.